Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Understand Cervical Cancer Early Endpoints and Determinants (SUCCEED)

NCT00339989 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00339989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00339989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Understand Cervical Cancer Early Endpoints and Determinants (SUCCEED)
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
September 12, 2003
Completion date
March 11, 2020
Enrollment
3,013 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, cervical intraepithelial, cin, neoplasia